Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 3/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | EGFR | P00533 | 12/20 | 0.80 |
| ▸ | KDR | P35968 | 9/20 | 0.76 |
| ▸ | RET | P07949 | 6/20 | 0.76 |
| ▸ | KIF5B | P33176 | 5/20 | 0.76 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.76 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.71 |
| ▸ | GAK | O14976 | 2/20 | 0.71 |
| ▸ | STK10 | O94804 | 1/20 | 0.71 |
| ▸ | FLT3 | P36888 | 1/20 | 0.71 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.71 |
| ▸ | Q6ZSR9 | Q6ZSR9 | 1/20 | 0.71 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.71 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.71 |
| ▸ | RPS6KA6 | Q9UK32 | 1/20 | 0.71 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.71 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.71 |
| ▸ | CLK1 | P49759 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29372372 | 1.00 | JAK3 (1.00) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL29651 | 1.00 | JAK3 (1.00) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL5570070 | 0.89 | EGFR (0.85) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL4469673 | 0.88 | JAK3 (0.79) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL6068633 | 0.86 | KDR (0.82) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL5865262 | 0.86 | EGFR (0.81) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL323445 | 0.86 | JAK3 (1.00) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL30925305 | 0.86 | JAK3 (1.00) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL5864546 | 0.85 | KDR (0.82) | JAK3ABCG2ABCB1EGFRKDR | |
| SCHEMBL20812874 | 0.85 | EGFR (0.80) | JAK3ABCG2ABCB1EGFRKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023286088-A1 | METHODS AND COMPOSITIONS FOR VIRAL VECTOR TRANSDUCTION | Indian Institute Of Science Education And Research Bhopal (IN) | 2023-01-19 | — | — | WO | claimed |
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | REGENERON PHARMA (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| US-12472241-B2 | Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors | REGENERON PHARMACEUTICALS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| EP-4629993-A1 | METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS | Kartos Therapeutics (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-3782649-B1 | BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS | ASCENDIS PHARMA AS (DK) | 2025-05-14 | — | — | EP | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024124240-A1 | METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS | KARTOS THERAPEUTICS (US) | 2024-06-13 | — | — | WO | disclosed |
| US-20230381323-A1 | RELEASABLE CONJUGATES | FISH & RICHARDSON PC | 2023-11-30 | — | — | US | disclosed |
| US-11786599-B2 | Releasable conjugates | QUIAPEG PHARMACEUTICALS AB (SE) | 2023-10-17 | — | — | US | disclosed |
| US-20230123784-A1 | Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels | ASCENDIS PHARMA A/S (DK) | 2023-04-20 | — | — | US | disclosed |
| US-11559482-B2 | Biodegradable polyethylene glycol based water-insoluble hydrogels | ASCENDIS PHARMA A/S (DE) | 2023-01-24 | — | — | US | disclosed |
| WO-2023286088-A1 | METHODS AND COMPOSITIONS FOR VIRAL VECTOR TRANSDUCTION | Indian Institute Of Science Education And Research Bhopal (IN) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023286088-A1 | METHODS AND COMPOSITIONS FOR VIRAL VECTOR TRANSDUCTION | Indian Institute Of Science Education And Research Bhopal (IN) | 2023-01-19 | — | — | WO | disclosed |
| EP-4011396-A1 | RELEASABLE CONJUGATES | QuiaPEG Pharmaceuticals AB (SE) | 2022-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230123784-A1 | Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels | PLG, PHYKPL, PLOD3 | JAK3 513/4885ABCG2 117/4885ABCB1 1197/4885 |
| US-20230381323-A1 | RELEASABLE CONJUGATES | GUSB, ABCB11, UGT2B7 | JAK3 4492/4885ABCG2 21/4885ABCB1 5/4885 |
| US-11559482-B2 | Biodegradable polyethylene glycol based water-insoluble hydrogels | PLG, PHYKPL, PLOD3 | JAK3 513/4885ABCG2 117/4885ABCB1 1197/4885 |
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | ALOX15, ALOX15B, ALOX5 | JAK3 4054/4885ABCG2 2563/4885ABCB1 1211/4885 |
| US-11786599-B2 | Releasable conjugates | GUSB, ABCB11, UGT2B7 | JAK3 4492/4885ABCG2 21/4885ABCB1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.